Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Novel Therapies for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: A Review of Clinical Trials

Ahmad Iftikhar, MD, Muhammad Ahmad, MBBS, Pranali Pachika, MD, Faryal Razzaq, MBBS, Muhammad Ashar Ashar Ali, Hizra Farrukh, MBBS, Azka Latif, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-142903

Published: 2020

Journal Articles

Ixazomib Based Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Anum Javaid, MD, Faryal Razzaq, MBBS, Muhammad Ashar Ali, MD, Muhammad Abu Zar, MD, Atif Sohail, MD MBBS, Ahmad Iftikhar, MD, Rana Usman, MD, Muhammad Yasir Anwar, Hamza Hassan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-141620

Published: 2020

Journal Articles

Efficacy and Safety Profile of Ixazomib Based Regimens in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Trials

Ahmad Iftikhar, MD, Muhammad Ashar Ali, MD, Anum Javaid, MD, Muhammad Abu Zar, MD, Atif Sohail, MD MBBS, Faryal Razzaq, MBBS, Rana M Usman, MD MBBS, BSc, Muhammad Yasir Anwar, Hamza Hassan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141984

Published: 2020

Journal Articles

Patterns of Relapse and Treatment for Relapsed/Refractory AL Amyloidosis: A Systematic Review

Adeela Mushtaq, MD, Hamza Hassan, MD MBBS, Razwana Khanam, MD, Ahmad Iftikhar, MD, Midhat Lakhani, MD, Muhammad Abdullah Yousaf, MBBS, MD, Muhaddis Ejaz Ahmad, MD, Maaz Ahmed Yusufi, MD, Seemal Iftikhar, MD, Aneeqa A Zafar, MD, Irbaz Riaz, MDMMSc, M Hasib Sidiqi, MBBS, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5556.

https://doi.org/10.1182/blood-2019-125148

Published: 2019

Journal Articles

Efficacy and Safety Profile of Bortezomib Based Regimens for Treatment of Newly Diagnosed Amyloidosis: A Systematic Review of Literature

Muhammad Abdullah Yousaf, MBBS, MD, Muhaddis Ejaz Ahmad, MD, Maaz Ahmed Yusufi, MD, Hamza Hassan, MD MBBS, Adeela Mushtaq, MD, Ahmad Iftikhar, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Zunairah Shah, MBBS, Ahmed Ibrahim, Adnan Basheer, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5583.

https://doi.org/10.1182/blood-2019-127190

Published: 2019

Journal Articles

Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Adeela Mushtaq, MD, Ahmad Iftikhar, MD, Midhat Lakhani, MD, Fnu Sagar, MD, Ahmad Kamal, MD, Umar Zahid, MD MPH, Hamza Hassan, MD, Zeeshan Ali, MD, Faryal Razzaq, MBBS, Saad Ullah Malik, MD, Syeda Fatima Hassan, MBBS, Muhammad Abu Zar, MD, Mohammad Bilal Chaudhary, MD, Ahmad Safdar, Mohamed Mokhtar Bakr, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 2022.

https://doi.org/10.1182/blood-2018-99-111439

Published: 2018

Journal Articles

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

Pavan Tenneti, MD, Umar Zahid, MD, Ahmad Iftikhar, MD, Seongseok Yun, MD PhD, Vikas Kapoor, MD, Azka Latif, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 2014.

https://doi.org/10.1182/blood.V130.Suppl_1.2014.2014

Published: 2017

Journal Articles

A Decade of Drug Development through Phase-1 Trials; Systematic Review of Literature for Novel Drugs and Targets in Multiple Myeloma

Imad Ud Deen, MBBS, Muhammad Umar Khalid, MD, Atlantis Dawn Russ, MD PhD, Anh Hua, BS, Ahmad Iftikhar, MD, Adeela Mushtaq, MD, Ahmad Safdar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5399.

https://doi.org/10.1182/blood.V130.Suppl_1.5399.5399

Published: 2017

Journal Articles

Precision Therapy Targeting Signal Transduction Aberrant Pathways in Multiple Myeloma

Raahem Nayab Zafar, BS, Atlantis Dawn Russ, MD PhD, Ahmad Iftikhar, MD, Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Pavan Tenneti, MD, Mirza Zeeshan Baig, MD, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5403.

https://doi.org/10.1182/blood.V130.Suppl_1.5403.5403

Published: 2017

Journal Articles

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Azka Latif, MD, Vikas Kapoor, MD, Faisal Akbar, MD, Ali McBride, PharmD,MS, Ahmad Iftikhar, MD, Pavan Tenneti, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Hafiz Muhammad Fazeel, MD, Syeda Sabeeka Batool, MBBS, Zabih Warraich, MD, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5411.

https://doi.org/10.1182/blood.V130.Suppl_1.5411.5411

Published: 2017

Journal Articles

Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review

Adeela Mushtaq, MD, Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Ahmad Iftikhar, MD, Pavan Tenneti, MD, Raahem Nayab Zafar, BS, Atlantis Dawn Russ, MD PhD, Ivo Abraham, PhD RN, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5413.

https://doi.org/10.1182/blood.V130.Suppl_1.5413.5413

Published: 2017

Journal Articles

Emerging Immune Targets for Treatment of Multiple Myeloma

Atif Sohail, MD MBBS, Adeela Mushtaq, MD, Ahmad Iftikhar, MD, Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Mirza Zeeshan Baig, MD, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5429.

https://doi.org/10.1182/blood.V130.Suppl_1.5429.5429

Published: 2017

Journal Articles

Does Your Smoldering Myeloma Patient Need Treatment? Evidence Based Recommendations

Rafiullah, MD, Umar Zahid, MD, Irbaz Bin Riaz, MDMMSc, Ali McBride, PharmD,MS, Ahmad Iftikhar, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Guido J. Tricot, MD PhD, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5431.

https://doi.org/10.1182/blood.V130.Suppl_1.5431.5431

Published: 2017

Journal Articles

Disease Milestones through Bibliometeric Analysis of Top 100 Cited Articles in Multiple Myeloma

Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Adeela Mushtaq, MD, Ahmad Iftikhar, MD, Faiz Anwer, MD, Jawad Bilal, MD

Blood (2017) 130 (Supplement 1): 5420.

https://doi.org/10.1182/blood.V130.Suppl_1.5420.5420

Published: 2017

NARROW

Novel Therapies for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: A Review of Clinical Trials

Ixazomib Based Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Efficacy and Safety Profile of Ixazomib Based Regimens in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Trials

Patterns of Relapse and Treatment for Relapsed/Refractory AL Amyloidosis: A Systematic Review

Efficacy and Safety Profile of Bortezomib Based Regimens for Treatment of Newly Diagnosed Amyloidosis: A Systematic Review of Literature

Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

A Decade of Drug Development through Phase-1 Trials; Systematic Review of Literature for Novel Drugs and Targets in Multiple Myeloma

Precision Therapy Targeting Signal Transduction Aberrant Pathways in Multiple Myeloma

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review

Emerging Immune Targets for Treatment of Multiple Myeloma

Does Your Smoldering Myeloma Patient Need Treatment? Evidence Based Recommendations

Disease Milestones through Bibliometeric Analysis of Top 100 Cited Articles in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only